共 50 条
- [41] Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma - A southwest oncology group studyCANCER, 2005, 104 (08) : 1627 - 1632Vaishampayan, UNFaulkner, JRSmall, EJRedman, BGKeiser, WLPetrylak, DPCrawford, ED
- [42] Phase II trial of inetforrnin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreasJOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)Rubin De Celia Ferrari, Anezlca CarvalhoFlesch Pfiffer, Tulio EduardoAlex, Alexandra KhichfyNebulonl, Danielle R.Carnelro, Allyne Q.Caparell, Fernanda CunhaSenna Leite, Luiz AntonioFreitas Meiro Braghiroli, Maria IgnezLobo, JulianaHoff, Paulo MarceloRiechelmann, Rachel Pimenta
- [43] Phase II Trial of Paclitaxel, Carboplatin and Gemcitabine in Patients With Locally Advanced Carcinoma of the BladderJOURNAL OF UROLOGY, 2008, 180 (06): : 2384 - 2388Smith, David C.Mackler, Niklas J.Dunn, Rodney L.Hussain, MahaWood, DavidLee, Cheryl T.Sanda, MartinVaishampayan, UlkaPetrylak, Daniel P.Quinn, David I.Beekman, KathleenMontie, James E.
- [44] Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreasECANCERMEDICALSCIENCE, 2015, 9Braghiroli, Maria Ignezde Celis Ferrari, Anezka C. R.Pfiffer, Tulio EduardoAlex, Alexandra KichfyNebuloni, DanielaCarneiro, Allyne S.Caparelli, FernandaSenna, LuizLobo, JulianaHoff, Paulo MarceloRiechelmann, Rachel P.
- [45] Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinomaCANCER, 2001, 92 (03) : 569 - 577Philip, PAZalupski, MMVaitkevicius, VKArlauskas, PChaplen, RHeilbrun, LKAdsay, VWeaver, DShields, AF
- [46] Weekly chemotherapy with docetaxel, gemcitabine and cisplatin in advanced transitional cell urothelial cancer: a phase II trialANNALS OF ONCOLOGY, 2002, 13 (02) : 243 - 250Pectasides, DGlotsos, JBountouroglou, NKouloubinis, AMitakidis, NKarvounis, NZiras, NAthanassiou, A
- [47] Cisplatin, gemcitabine, and ifosfamide as weekly therapy: A feasibility and phase II study of salvage treatment for advanced transitional-cell carcinomaJOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (13) : 2965 - 2970Pagliaro, LCMillikan, RETu, SMWilliams, DDaliani, DPapandreou, CNLogothetis, CJ
- [48] Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract -: Final report of a phase II trial evaluating two dosing schedulesCANCER, 2000, 88 (07) : 1671 - 1678Bajorin, DFMcCaffrey, JADodd, PMHilton, SMazumdar, MKelly, WKHerrr, HScher, HIIcasiano, EHiggins, G
- [49] PHASE-II TRIAL WITH CISPLATIN, DOXORUBICIN, AND CYCLOPHOSPHAMIDE (CAP) IN THE TREATMENT OF UROTHELIAL TRANSITIONAL CELL-CARCINOMACANCER TREATMENT REPORTS, 1981, 65 (9-10): : 897 - 899CAMPBELL, MBAKER, LHOPIPARI, MALSARRAF, M
- [50] Extended follow-up report of a randomized phase II trial comparing gemcitabine and cisplatin with or without berzosertib in patients with advanced urothelial carcinoma.JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 614 - 614Parikh, MamtaPal, Sumanta KumarFrankel, Paul HenryRuel, ChristopherMortazavi, AmirMilowsky, Matthew I.Vaishampayan, Ulka N.Lyou, YungWang, PengParikh, Rahul AtulTeply, Benjamin A.Dreicer, RobertEmamekhoo, HamidMichaelson, Dror DrorHoimes, Christopher J.Zhang, TianSrinivas, SandyKim, William Y.Liu, GlennLara, Primo N.